{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:03:13Z","timestamp":1791655393905,"version":"4.3.4"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"18","license":[{"start":{"date-parts":[[2002,9,15]],"date-time":"2002-09-15T00:00:00Z","timestamp":1032048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2002,9,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>CpG methylation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat (LTR) has been implicated in proviral latency, but there is presently little information available regarding the pattern of LTR methylation and its effect on viral gene expression. To gain insight into the mechanisms of HTLV-1 latency, we have studied methylation of individual CpG sites in the U3-R region of the integrated proviral LTR by using bisulfite genomic sequencing methods. Surprisingly, our results reveal selective hypermethylation of the 5\u2032 LTR and accompanying hypomethylation of the 3\u2032 LTR in both latently infected cell lines and adult T-cell leukemia (ATL) cells having a complete provirus. Moreover, we observed a lack of CpG methylation in the LTRs of 5\u2032-defective proviruses recovered from ATL samples, which is consistent with the selective hypomethylation of the 3\u2032 LTR. Thus, the integrated HTLV-1 provirus in these carriers appears to be hypermethylated in the 5\u2032 LTR and hypomethylated in the 3\u2032 LTR. These results, together with the observation that proviral gene expression is reactivated by 5-azacytidine in latently infected cell lines, indicate that selective hypermethylation of the HTLV-1 5\u2032 LTR is common both in vivo and in vitro. Thus, hypermethylation of the 5\u2032 LTR appears to be an important mechanism by which HTLV-1 gene expression is repressed during viral latency.<\/jats:p>","DOI":"10.1128\/jvi.76.18.9389-9397.2002","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T19:36:19Z","timestamp":1033500979000},"page":"9389-9397","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":214,"title":["5\u2032-Long Terminal Repeat-Selective CpG Methylation of Latent Human T-Cell Leukemia Virus Type 1 Provirus In Vitro and In Vivo"],"prefix":"10.1128","volume":"76","author":[{"given":"Tsukasa","family":"Koiwa","sequence":"first","affiliation":[{"name":"Division of Pathology, Department of Cancer Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Hamano-Usami","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Cancer Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi","family":"Ishida","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Cancer Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Okayama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Medical College, Miyazaki 889-1601"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Blood Transfusion Service, Kumamoto University, Kumamoto 860-8556"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimeru","family":"Kamihira","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nagasaki University, Nagasaki 852-8523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Cancer Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60702-2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.16.2395"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-11-3255"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Clark S. J. J. Harrison C. L. Paul and M. Frommer. 1994. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22 : 2990-2997.","DOI":"10.1093\/nar\/22.15.2990"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(84)90120-X"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.18.8277-8285.2000"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0895"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1412"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.19.6207"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.4.987"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.7.1865.bloodjournal8571865"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Gessain A. F. Barin J. C. Vernant O. Gout L. Maurs A. Calender and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii: 407-410.","DOI":"10.1016\/S0140-6736(85)92734-5"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.2.428.428"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.35.22322"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.12.7609"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.13.8.4523-4530.1993"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910290606"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6476"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.3.1558-1567.1991"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.49.1.66-71.1984"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.10.4860-4867.2000"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.14.5620"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910350510"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1993.tb05755.x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.5.2305-2312.2000"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/08892220050193100"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/366362a0"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.78.2.149"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1992.tb00092.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.5.367"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6290"},{"key":"e_1_3_2_33_2","first-page":"5","volume":"76","year":"1985","unstructured":"Ogawa, Y., N. Sagata, J. Tsuzuku-Kawamura, M. Onuma, H. Izawa, and Y. Ikawa. 1985. Methylation pattern of the bovine leukemia provirus genome in bovine leukemic cells. Jpn. J. Cancer Res. 76 : 5-8.","journal-title":"Jpn. J. Cancer Res."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","unstructured":"Osame M. K. Usuku S. Izumo N. Ijichi H. Amitani A. Igata M. Matsumoto and M. Tara. 1986. HTLV-I associated myelopathy a new clinical entity. Lancet i: 1031-1032.","DOI":"10.1016\/S0140-6736(86)91298-5"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"e_1_3_2_36_2","first-page":"97","volume":"81","year":"2000","unstructured":"Rose, N. J., J. H. Richardson, U. Desselberger, and A. M. Lever. 2000. Virus inactivation in a proportion of human T-cell leukaemia virus type I-infected T-cell clones arises through naturally occurring mutations. J. Gen. Virol. 81 : 97-104.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90649-V"},{"key":"e_1_3_2_38_2","first-page":"4968","volume":"50","year":"1990","unstructured":"Saggioro, D., M. Panozzo, and L. Chieco-Bianchi. 1990. Human T-lymphotropic virus type I transcriptional regulation by methylation. Cancer Res. 50 : 4968-4973.","journal-title":"Cancer Res."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80725-4"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(99)00031-3"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.9.3080.3080"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V50.3.481.481"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910320313"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-5710(97)00077-7"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.5.2863-2868.1995"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.76.18.9389-9397.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.76.18.9389-9397.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T07:21:19Z","timestamp":1646464879000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.76.18.9389-9397.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,15]]},"references-count":45,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2002,9,15]]}},"alternative-id":["10.1128\/JVI.76.18.9389-9397.2002"],"URL":"https:\/\/doi.org\/10.1128\/jvi.76.18.9389-9397.2002","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,15]]},"assertion":[{"value":"2002-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-06-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-09-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}